IL6 and malaria: Activation of GPR37 through neuroprotectin D1 (NPD1) and artesunate (ARU) has been shown to decrease serum interleukin-6 (IL-6) levels in WT mice infected with LPS, Listeria, and malaria parasites, thereby mitigating inflammation and reducing mortality (Bang et al., 2021).